Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and ...

The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...

KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...

Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

Matt Keil, who was the bassist of Canadian band Comeback Kid before becoming a realtor in the Twin Cities, has died following ...

The Longitude Prize on ALS has launched to find AI-based approaches to help transform treatment of amyotrophic lateral sclerosis (ALS).

For more than 25 years, the local community has gathered at the annual Walk to Defeat ALS Johnstown event, and for nearly that entire time, Jeremy Portash has been involved. He and his family, who ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...

The U.S. FDA has granted orphan drug designation to Klotho Neurosciences Inc.’s secreted-Klotho (s-KL) promoter, gene and ...

A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...